CompoSecure, Inc. (NASDAQ:CMPO - Free Report) - Investment analysts at B. Riley cut their FY2025 earnings estimates for CompoSecure in a research report issued on Thursday, March 6th. B. Riley analyst H. Goetsch now expects that the company will post earnings per share of $0.93 for the year, down from their previous forecast of $1.12. The consensus estimate for CompoSecure's current full-year earnings is $1.02 per share. B. Riley also issued estimates for CompoSecure's FY2026 earnings at $1.10 EPS.
Several other research firms also recently commented on CMPO. Needham & Company LLC reduced their price objective on CompoSecure from $16.00 to $15.00 and set a "buy" rating for the company in a research note on Thursday, March 6th. JPMorgan Chase & Co. cut their price target on shares of CompoSecure from $16.00 to $15.00 and set a "neutral" rating for the company in a report on Thursday, March 6th. TD Cowen assumed coverage on CompoSecure in a report on Wednesday, December 18th. They issued a "buy" rating and a $20.00 price objective on the stock. Finally, Lake Street Capital cut their price objective on CompoSecure from $18.00 to $15.00 and set a "buy" rating for the company in a research report on Thursday, March 6th. One equities research analyst has rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $16.19.
Get Our Latest Research Report on CMPO
CompoSecure Stock Down 5.3 %
Shares of NASDAQ CMPO traded down $0.59 during midday trading on Monday, hitting $10.38. The stock had a trading volume of 811,448 shares, compared to its average volume of 747,801. The stock has a 50 day simple moving average of $14.71 and a 200-day simple moving average of $14.57. The company has a market capitalization of $1.06 billion, a PE ratio of -23.60, a P/E/G ratio of 2.63 and a beta of 0.77. CompoSecure has a 1 year low of $5.58 and a 1 year high of $17.71.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Principal Financial Group Inc. grew its stake in shares of CompoSecure by 9.3% during the fourth quarter. Principal Financial Group Inc. now owns 11,399 shares of the company's stock worth $175,000 after purchasing an additional 967 shares in the last quarter. Bard Associates Inc. boosted its position in shares of CompoSecure by 0.6% during the 3rd quarter. Bard Associates Inc. now owns 305,247 shares of the company's stock worth $4,280,000 after acquiring an additional 1,957 shares in the last quarter. First Trust Advisors LP increased its holdings in shares of CompoSecure by 2.2% in the 4th quarter. First Trust Advisors LP now owns 100,124 shares of the company's stock valued at $1,535,000 after acquiring an additional 2,149 shares during the last quarter. Ameriprise Financial Inc. raised its position in shares of CompoSecure by 1.9% during the 4th quarter. Ameriprise Financial Inc. now owns 133,399 shares of the company's stock worth $2,045,000 after acquiring an additional 2,521 shares in the last quarter. Finally, Mitsubishi UFJ Asset Management Co. Ltd. lifted its stake in CompoSecure by 33.3% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 10,201 shares of the company's stock worth $161,000 after purchasing an additional 2,547 shares during the last quarter. Institutional investors and hedge funds own 37.56% of the company's stock.
Insider Activity at CompoSecure
In related news, Director Resolute Compo Holdings Llc acquired 233,070 shares of the stock in a transaction dated Thursday, February 20th. The stock was acquired at an average cost of $16.57 per share, with a total value of $3,861,969.90. Following the completion of the transaction, the director now owns 879,963 shares in the company, valued at $14,580,986.91. This represents a 36.03 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CRO Amanda Mandy Gourbault sold 9,622 shares of the firm's stock in a transaction that occurred on Thursday, February 27th. The shares were sold at an average price of $16.09, for a total transaction of $154,817.98. Following the completion of the sale, the executive now directly owns 821,782 shares in the company, valued at approximately $13,222,472.38. This trade represents a 1.16 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders acquired 659,376 shares of company stock worth $10,429,021. Corporate insiders own 74.99% of the company's stock.
About CompoSecure
(
Get Free Report)
CompoSecure, Inc manufactures and designs metal, composite, and proprietary financial transaction cards in the United States and internationally. Its primary metal form factors include embedded, metal veneer lite, metal veneer, and full metal products. The company also offers Arculus Cold Storage Wallet, a three-factor authentication solution, which supports specific digital assets, including Bitcoin, Ethereum, non-fungible tokens and others.
Further Reading
Before you consider CompoSecure, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CompoSecure wasn't on the list.
While CompoSecure currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.